Pilot Phase III immunotherapy study in early breast cancer patients using oxidized mannan-MUC1 [mannan-MUC1 fusion protein]
Latest Information Update: 07 Nov 2006
At a glance
- Drugs OM-MUC 1 (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms IFCM9
- 07 Nov 2006 New trial record.